Treatment for Pheochromocytoma, Paraganglioma to Be Discontinued
Progenics Pharmaceuticals will stop producing Azedra (iobenguane I 131) injection due to a lack of commercial demand.
Source: cancertherapyadvisor.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Azedra Injection. Real-time updates on events, politics, business and more.